<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-798
Date of Submission: 2025-06-02

This report was submitted by a Physician from Alvarez, White and Wood Medical Center concerning patient ANON-PX-3726. The subject is a 70-year-old other with a significant medical history including asthma, osteoarthritis, anxiety. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Warfarin administered via the Subcutaneous route at a dosage of 312mg, initiated on 2025-05-10 for Thromboembolism prevention with the course ongoing.

On approximately 2025-05-25, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Anaphylaxis, Stevens-Johnson syndrome, Angioedema, Pruritus. The Anaphylaxis was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed democratic and advised experience. The current patient status regarding this symptom is 'Unknown'. The Stevens-Johnson syndrome was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. The Angioedema was classified as Mild in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Unknown'. The Pruritus was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 8 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: World expect house partner. List inside car kind discover guy expert reality.</data>
report_id: ADR-2025-798
report_date: '2025-06-02'
patient_details:
  patient_id: ANON-PX-3726
  gender: Other
  relevant_history:
  - asthma
  - osteoarthritis
  - anxiety
  age_at_reaction: 70
suspected_drugs:
- drug_name: Warfarin
  dosage: 312mg
  route_of_administration: Subcutaneous
  start_date: '2025-05-10'
  indication_for_use: Thromboembolism prevention
adverse_reactions:
- symptom_name: Anaphylaxis
  onset_date: '2025-05-25'
  severity: Mild
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed democratic and advised experience.
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2025-05-25'
  severity: Life-threatening
  outcome: Recovered
  intervention_required: false
- symptom_name: Angioedema
  onset_date: '2025-05-25'
  severity: Mild
  outcome: Unknown
  intervention_required: true
- symptom_name: Pruritus
  onset_date: '2025-05-25'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Negative dechallenge
  naranjo_score: 8
reporting_facility: Alvarez, White and Wood Medical Center
reporter_type: Physician
notes: World expect house partner. List inside car kind discover guy expert reality.
